| abstract |
The present invention relates to methods of therapy of immunodeficient, immunosuppressive or immune hyperactive states, as well as methods of preventing and treating opportunistic infections occurring in such states. Said methods consist in administering to a subject a pharmaceutically acceptable composition containing, as active ingredient, the pentapeptide L-Thr-L-Ala-L-Glx-L-Glx-L-Lys and / or its pharmaceutically acceptable salts, Glx representing Gln or Glu. |